Login
Navigate Fool.com
Will PTN beat
the market?
Community Rating: 2 Stars: Unattractive

0.60 -0.03 (-4.90%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.62
Previous Close $0.63
Daily Range $0.60 - $0.62
52-Week Range $0.40 - $1.20
Market Cap $23.2M
P/E Ratio -1.96
Dividend (Yield) $0.00 (0.0%)
Volume 7,740
Average Daily Volume 78,301
Current FY EPS -$0.22

How do you think PTN
will perform against the market?

Top PTN Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted August 8, 2011

Another one of my long-shot micro picks that nearly doubled before nearly trapping me in a losing score due to the big plunge. Fortunately I jumped ship just in time and now I'm back in, no doubt too … More

0 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

The 10 Most-Watched Diagnostic Substances Stocks

The 10 diagnostic substances stocks our community is most interested in.

Pre-Market Earnings Report for September 11, 2012 : UNFI, AEPI, HSOL, PTN

Pre-Market Earnings Report for September 11, 2012 : UNFI, AEPI, HSOL, PTN

Palatin Tech Says AstraZeneca Halts Further Development of Obesity Drug

Setback for AZN Obesity Drug - Analyst Blog

Palatin, AstraZeneca Obesity Drug Trial Halted on Adverse Event

Palatin Tech 4Q Loss Widens Sharply As Revenue Plunges

P&G Patches Up Sex Life?

A study reveals that a testosterone patch for women can be effective.

See More PTN News...

Sector

Healthcare

Industry

Drugs

Palatin Technologies, Inc. (PTN) Description

A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics. Website: http://www.palatin.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks